Associated Papers
Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer.
Tam KJ et al.
Scientific Reports, 2024
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
Cobain EF et al.
Jama Oncology, 2021
33630025 (PubMed )
Supplement: jamaoncol-e207987-s004.xlsx › Table
A genomic and epigenomic atlas of prostate cancer in Asian populations.
Li J et al.
Nature, 2020
Forkhead domain mutations in FOXA1 drive prostate cancer progression.
Gao S et al.
Cell Research, 2019
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.
Huang FW et al.
Cancer Discovery, 2017
Select a paper to view details